Cargando…

Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity

Tyrosine kinase inhibitors are known to cause pulmonary complications. We report a case of bosutinib related bilateral pleural effusions in a patient with chronic myeloid leukemia. Characteristics of the pleural fluid are presented. We also discuss other tyrosine kinase inhibitors induced pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moguillansky, Natalia I., Fakih, Hafiz Abdul Moiz, Wingard, John R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435591/ https://www.ncbi.nlm.nih.gov/pubmed/28560147 http://dx.doi.org/10.1016/j.rmcr.2017.05.003

Ejemplares similares

Transudative pleural effusion of malignant etiology: Rare but real
por: Johnson, Lindsey, et al.
Publicado: (2017)

Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain
por: Levinson, Nicholas M., et al.
Publicado: (2012)

A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib
por: Seegobin, Karan, et al.
Publicado: (2017)

Bosutinib-Induced Stevens-Johnson Syndrome and Evidence of Tolerance to a Structurally Dissimilar Tyrosine Kinase Inhibitor
por: Avila-Castano, Karol, et al.
Publicado: (2022)

Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia
por: Rassi, Fuad El, et al.
Publicado: (2013)

Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
por: Liu, Qiuying (Selina), et al.
Publicado: (2021)

Tyrosine Kinase Inhibitor Induced Isolated Pericardial Effusion
por: Agrawal, Vineet, et al.
Publicado: (2015)

Micro-osmotic pumps for continuous release of the tyrosine kinase inhibitor bosutinib in juvenile rats and its impact on bone growth
por: Tauer, Josephine Tabea, et al.
Publicado: (2013)

Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling
por: Bieerkehazhi, Shayahati, et al.
Publicado: (2016)

Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study
por: Isfort, Susanne, et al.
Publicado: (2023)

EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
por: Yang, Jiyoul, et al.
Publicado: (2018)

Long‐term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors
por: Gambacorti‐Passerini, Carlo, et al.
Publicado: (2015)

Pleural effusion: An uncommon manifestation of nitrofurantoin-induced pulmonary injury
por: Davis, Jared W., et al.
Publicado: (2016)

Asciminib vs bosutinib in CML patients pretreated with ≥2 tyrosine kinase inhibitors: Results from the Japanese subgroup analysis of ASCEMBL study
por: Yuda, Junichiro, et al.
Publicado: (2022)

Bosutinib: A Novel Src/Abl Kinase Inhibitor for Chronic Myelogenous Leukemia
por: Steinbach, Alison, et al.
Publicado: (2013)

Incident pulmonary arterial hypertension associated with Bosutinib
por: Yo, Shaun, et al.
Publicado: (2020)

Warfarin-Induced Eosinophilic Pleural Effusion
por: Jo, Yong-Min, et al.
Publicado: (2011)

Dasatinib induced pleural effusions - Reply
por: AJ Abdulla, Mohammad, et al.
Publicado: (2020)

Dasatinib-Induced Pleural and Pericardial Effusions
por: Hailan, Yousef M, et al.
Publicado: (2021)

Dasatinib-Induced Bilateral Pleural Effusions
por: Rasul, Taha F, et al.
Publicado: (2022)

The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases
por: Ozanne, James, et al.
Publicado: (2015)

Pulmonary Silicosis Presents with Pleural Effusion
por: Salih, Mohsin, et al.
Publicado: (2015)

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma
por: Verma, Akash, et al.
Publicado: (2016)

Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event
por: Pasquale, Raffaella, et al.
Publicado: (2022)

Cocaine Induced Pleural and Pericardial Effusion Syndrome
por: Alqalyoobi, Shehabaldin, et al.
Publicado: (2015)

Clozapine-Induced Liver Injury and Pleural Effusion
por: Kane, Joseph P.M., et al.
Publicado: (2014)

Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion
por: Tian, Tian, et al.
Publicado: (2019)

Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL
por: Hochhaus, Andreas, et al.
Publicado: (2023)

Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study
por: Cortes, Jorge E., et al.
Publicado: (2023)

Incidence of Pleural Effusion in Patients with Pulmonary Embolism
por: Liu, Min, et al.
Publicado: (2015)

Abrogation of transforming growth factor-β-induced tissue fibrosis in TBRI(ca)Col1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib)
por: Wermuth, Peter J., et al.
Publicado: (2018)

Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions
por: Hummelink, Karlijn, et al.
Publicado: (2019)

Pleural Effusion
por: Gray, Frank D.
Publicado: (1963)

Pleural Effusion
por: Brunton, T. Lauder
Publicado: (1898)

Pleural Effusion
por: Sherding, Robert G., et al.
Publicado: (2006)

Pleural Effusions
Publicado: (1877)

Pulmonary melioidosis presenting with pleural effusion: A case report and review of literature
por: Soo, Chun Ian, et al.
Publicado: (2015)

Carbimazole Induced Pleural Effusion: A Case Report
por: Das, Gautam, et al.
Publicado: (2012)

Dasatinib-induced pleural effusion: Chylothorax, an option to consider
por: Ferreiro, Lucía, et al.
Publicado: (2016)

Methimazole-Induced Pleural Effusion in the Setting of Graves' Disease
por: Khine, Le Yu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3tobn6risfoc9i37cn6385t6eb